The cobas® PIK3CA Mutation Test is a highly sensitive, real-time polymerase chain reaction (PCR) test for the qualitative detection and identification of PIK3CA mutations in patients with advanced or metastatic breast cancer. The cobas® PIK3CA Mutation Test detects 17 mutations in exons 2, 5, 8, 10, and 21 in the gene encoding the catalytic subunit of PIK3CA in DNA isolated from formalin-fixed paraffin-embedded tumor tissue (FFPET).
From sample to analysis and insights, the cobas® PIK3CA Mutation Test provides accurate, reliable results in less than 8 hours. Using a simple, standardized workflow with the cobas® z 480 Analyzer, laboratories have the flexibility to mix-batch sample types from different oncology assays and process up to 30 samples in a single run. The cobas® PIK3CA Mutation Test offers high quality, fast results, improving laboratory efficiency and allowing healthcare professionals to make confident treatment decisions sooner.
References
